Caroline Costa

Title: Caroline Costa: Innovator in Vector Particle Technology

Introduction

Caroline Costa is a prominent inventor based in Lyons, France. She has made significant contributions to the field of biotechnology, particularly in the development of vector particles for targeted cell therapy. With a total of 2 patents, her work is paving the way for advancements in medical treatments.

Latest Patents

One of Caroline's latest patents focuses on vector particles for targeting CD34+ cells. This invention relates to a vector particle designed for transferring biological material into cells. The vector particle comprises a first protein that includes the transmembrane and extracellular domains of the feline endogenous RD114 virus envelope glycoprotein. Additionally, it features a second protein that acts as a ligand for the c-Kit receptor. This innovative approach has the potential to enhance the efficacy of targeted therapies.

Career Highlights

Caroline is currently affiliated with the Institut National de la Santé et de la Recherche Médicale, where she continues to push the boundaries of research in her field. Her dedication to innovation and excellence has established her as a key figure in biotechnology.

Collaborations

Caroline has collaborated with esteemed colleagues, including Els Verhoeyen and Cecilia Frecha, contributing to a dynamic research environment that fosters creativity and scientific advancement.

Conclusion

Caroline Costa's work in vector particle technology exemplifies the impact of innovative thinking in biotechnology. Her contributions are vital for the future of targeted therapies, and her ongoing research promises to yield significant advancements in medical science.